Global Erectile Dysfunction (ED) Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Based on the Erectile Dysfunction (ED) Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Erectile Dysfunction (ED) Drugs market covered in Chapter 5:
Cristália
Vivus, Inc
Pfizer, Inc
Pfizer, Inc
Apricus Biosciences
S.K. Chemicals Co., Ltd
Dong-A-Pharmaceutical Co., Ltd
Teva Pharmaceutical Industries Ltd
Bayer AG
Meda Pharmaceuticals, Inc
Eli Lilly and Company, Inc
In Chapter 6, on the basis of types, the Erectile Dysfunction (ED) Drugs market from 2015 to 2025 is primarily split into:
Sildenafil Citrate (Viagra)
Vardenafil (Levitra/ Staxyn)
Tadalafil (Cialis)
Udenafil (Zydena)
Lodenafil Carbonate (Helleva)
Stendra/ Spedra (Avanafil)
Mirodenafil (Mvix)
Others
In Chapter 7, on the basis of applications, the Erectile Dysfunction (ED) Drugs market from 2015 to 2025 covers:
Hospital Pharmacies
Retail Pharmacies
Online Sales
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Erectile Dysfunction (ED) Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Cristália
5.1.1 Cristália Company Profile
5.1.2 Cristália Business Overview
5.1.3 Cristália Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Cristália Erectile Dysfunction (ED) Drugs Products Introduction
5.2 Vivus, Inc
5.2.1 Vivus, Inc Company Profile
5.2.2 Vivus, Inc Business Overview
5.2.3 Vivus, Inc Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Vivus, Inc Erectile Dysfunction (ED) Drugs Products Introduction
5.3 Pfizer, Inc
5.3.1 Pfizer, Inc Company Profile
5.3.2 Pfizer, Inc Business Overview
5.3.3 Pfizer, Inc Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Pfizer, Inc Erectile Dysfunction (ED) Drugs Products Introduction
5.4 Pfizer, Inc
5.4.1 Pfizer, Inc Company Profile
5.4.2 Pfizer, Inc Business Overview
5.4.3 Pfizer, Inc Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Pfizer, Inc Erectile Dysfunction (ED) Drugs Products Introduction
5.5 Apricus Biosciences
5.5.1 Apricus Biosciences Company Profile
5.5.2 Apricus Biosciences Business Overview
5.5.3 Apricus Biosciences Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Apricus Biosciences Erectile Dysfunction (ED) Drugs Products Introduction
5.6 S.K. Chemicals Co., Ltd
5.6.1 S.K. Chemicals Co., Ltd Company Profile
5.6.2 S.K. Chemicals Co., Ltd Business Overview
5.6.3 S.K. Chemicals Co., Ltd Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 S.K. Chemicals Co., Ltd Erectile Dysfunction (ED) Drugs Products Introduction
5.7 Dong-A-Pharmaceutical Co., Ltd
5.7.1 Dong-A-Pharmaceutical Co., Ltd Company Profile
5.7.2 Dong-A-Pharmaceutical Co., Ltd Business Overview
5.7.3 Dong-A-Pharmaceutical Co., Ltd Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Dong-A-Pharmaceutical Co., Ltd Erectile Dysfunction (ED) Drugs Products Introduction
5.8 Teva Pharmaceutical Industries Ltd
5.8.1 Teva Pharmaceutical Industries Ltd Company Profile
5.8.2 Teva Pharmaceutical Industries Ltd Business Overview
5.8.3 Teva Pharmaceutical Industries Ltd Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Teva Pharmaceutical Industries Ltd Erectile Dysfunction (ED) Drugs Products Introduction
5.9 Bayer AG
5.9.1 Bayer AG Company Profile
5.9.2 Bayer AG Business Overview
5.9.3 Bayer AG Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Bayer AG Erectile Dysfunction (ED) Drugs Products Introduction
5.10 Meda Pharmaceuticals, Inc
5.10.1 Meda Pharmaceuticals, Inc Company Profile
5.10.2 Meda Pharmaceuticals, Inc Business Overview
5.10.3 Meda Pharmaceuticals, Inc Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Meda Pharmaceuticals, Inc Erectile Dysfunction (ED) Drugs Products Introduction
5.11 Eli Lilly and Company, Inc
5.11.1 Eli Lilly and Company, Inc Company Profile
5.11.2 Eli Lilly and Company, Inc Business Overview
5.11.3 Eli Lilly and Company, Inc Erectile Dysfunction (ED) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Eli Lilly and Company, Inc Erectile Dysfunction (ED) Drugs Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Erectile Dysfunction (ED) Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Erectile Dysfunction (ED) Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Erectile Dysfunction (ED) Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Erectile Dysfunction (ED) Drugs Price by Types (2015-2020)
6.2 Global Erectile Dysfunction (ED) Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Erectile Dysfunction (ED) Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Sildenafil Citrate (Viagra)
6.3.2 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Vardenafil (Levitra/ Staxyn)
6.3.3 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Tadalafil (Cialis)
6.3.4 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Udenafil (Zydena)
6.3.5 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Lodenafil Carbonate (Helleva)
6.3.6 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Stendra/ Spedra (Avanafil)
6.3.7 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Mirodenafil (Mvix)
6.3.8 Global Erectile Dysfunction (ED) Drugs Sales, Price and Growth Rate of Others
6.4 Global Erectile Dysfunction (ED) Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Sildenafil Citrate (Viagra) Market Revenue and Sales Forecast (2020-2025)
6.4.2 Vardenafil (Levitra/ Staxyn) Market Revenue and Sales Forecast (2020-2025)
6.4.3 Tadalafil (Cialis) Market Revenue and Sales Forecast (2020-2025)
6.4.4 Udenafil (Zydena) Market Revenue and Sales Forecast (2020-2025)
6.4.5 Lodenafil Carbonate (Helleva) Market Revenue and Sales Forecast (2020-2025)
6.4.6 Stendra/ Spedra (Avanafil) Market Revenue and Sales Forecast (2020-2025)
6.4.7 Mirodenafil (Mvix) Market Revenue and Sales Forecast (2020-2025)
6.4.8 Others Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Erectile Dysfunction (ED) Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Erectile Dysfunction (ED) Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Erectile Dysfunction (ED) Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Erectile Dysfunction (ED) Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Erectile Dysfunction (ED) Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Erectile Dysfunction (ED) Drugs Revenue, Sales and Growth Rate of Hospital Pharmacies (2015-2020)
7.3.2 Global Erectile Dysfunction (ED) Drugs Revenue, Sales and Growth Rate of Retail Pharmacies (2015-2020)
7.3.3 Global Erectile Dysfunction (ED) Drugs Revenue, Sales and Growth Rate of Online Sales (2015-2020)
7.4 Global Erectile Dysfunction (ED) Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospital Pharmacies Market Revenue and Sales Forecast (2020-2025)
7.4.2 Retail Pharmacies Market Revenue and Sales Forecast (2020-2025)
7.4.3 Online Sales Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Erectile Dysfunction (ED) Drugs Sales by Regions (2015-2020)
8.2 Global Erectile Dysfunction (ED) Drugs Market Revenue by Regions (2015-2020)
8.3 Global Erectile Dysfunction (ED) Drugs Market Forecast by Regions (2020-2025)
9 North America Erectile Dysfunction (ED) Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Erectile Dysfunction (ED) Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Erectile Dysfunction (ED) Drugs Market Analysis by Country
9.6.1 U.S. Erectile Dysfunction (ED) Drugs Sales and Growth Rate
9.6.2 Canada Erectile Dysfunction (ED) Drugs Sales and Growth Rate
9.6.3 Mexico Erectile Dysfunction (ED) Drugs Sales and Growth Rate
10 Europe Erectile Dysfunction (ED) Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Erectile Dysfunction (ED) Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Erectile Dysfunction (ED) Drugs Market Analysis by Country
10.6.1 Germany Erectile Dysfunction (ED) Drugs Sales and Growth Rate
10.6.2 United Kingdom Erectile Dysfunction (ED) Drugs Sales and Growth Rate
10.6.3 France Erectile Dysfunction (ED) Drugs Sales and Growth Rate
10.6.4 Italy Erectile Dysfunction (ED) Drugs Sales and Growth Rate
10.6.5 Spain Erectile Dysfunction (ED) Drugs Sales and Growth Rate
10.6.6 Russia Erectile Dysfunction (ED) Drugs Sales and Growth Rate
11 Asia-Pacific Erectile Dysfunction (ED) Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Erectile Dysfunction (ED) Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Erectile Dysfunction (ED) Drugs Market Analysis by Country
11.6.1 China Erectile Dysfunction (ED) Drugs Sales and Growth Rate
11.6.2 Japan Erectile Dysfunction (ED) Drugs Sales and Growth Rate
11.6.3 South Korea Erectile Dysfunction (ED) Drugs Sales and Growth Rate
11.6.4 Australia Erectile Dysfunction (ED) Drugs Sales and Growth Rate
11.6.5 India Erectile Dysfunction (ED) Drugs Sales and Growth Rate
12 South America Erectile Dysfunction (ED) Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Erectile Dysfunction (ED) Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Erectile Dysfunction (ED) Drugs Market Analysis by Country
12.6.1 Brazil Erectile Dysfunction (ED) Drugs Sales and Growth Rate
12.6.2 Argentina Erectile Dysfunction (ED) Drugs Sales and Growth Rate
12.6.3 Columbia Erectile Dysfunction (ED) Drugs Sales and Growth Rate
13 Middle East and Africa Erectile Dysfunction (ED) Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Erectile Dysfunction (ED) Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Erectile Dysfunction (ED) Drugs Market Analysis by Country
13.6.1 UAE Erectile Dysfunction (ED) Drugs Sales and Growth Rate
13.6.2 Egypt Erectile Dysfunction (ED) Drugs Sales and Growth Rate
13.6.3 South Africa Erectile Dysfunction (ED) Drugs Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Erectile Dysfunction (ED) Drugs Market Size and Growth Rate 2015-2025
Table Erectile Dysfunction (ED) Drugs Key Market Segments
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Erectile Dysfunction (ED) Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Cristália Company Profile
Table Cristália Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cristália Production and Growth Rate
Figure Cristália Market Revenue ($) Market Share 2015-2020
Table Vivus, Inc Company Profile
Table Vivus, Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Vivus, Inc Production and Growth Rate
Figure Vivus, Inc Market Revenue ($) Market Share 2015-2020
Table Pfizer, Inc Company Profile
Table Pfizer, Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer, Inc Production and Growth Rate
Figure Pfizer, Inc Market Revenue ($) Market Share 2015-2020
Table Pfizer, Inc Company Profile
Table Pfizer, Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer, Inc Production and Growth Rate
Figure Pfizer, Inc Market Revenue ($) Market Share 2015-2020
Table Apricus Biosciences Company Profile
Table Apricus Biosciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Apricus Biosciences Production and Growth Rate
Figure Apricus Biosciences Market Revenue ($) Market Share 2015-2020
Table S.K. Chemicals Co., Ltd Company Profile
Table S.K. Chemicals Co., Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure S.K. Chemicals Co., Ltd Production and Growth Rate
Figure S.K. Chemicals Co., Ltd Market Revenue ($) Market Share 2015-2020
Table Dong-A-Pharmaceutical Co., Ltd Company Profile
Table Dong-A-Pharmaceutical Co., Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dong-A-Pharmaceutical Co., Ltd Production and Growth Rate
Figure Dong-A-Pharmaceutical Co., Ltd Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd Company Profile
Table Teva Pharmaceutical Industries Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Industries Ltd Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd Market Revenue ($) Market Share 2015-2020
Table Bayer AG Company Profile
Table Bayer AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Market Revenue ($) Market Share 2015-2020
Table Meda Pharmaceuticals, Inc Company Profile
Table Meda Pharmaceuticals, Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Meda Pharmaceuticals, Inc Production and Growth Rate
Figure Meda Pharmaceuticals, Inc Market Revenue ($) Market Share 2015-2020
Table Eli Lilly and Company, Inc Company Profile
Table Eli Lilly and Company, Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eli Lilly and Company, Inc Production and Growth Rate
Figure Eli Lilly and Company, Inc Market Revenue ($) Market Share 2015-2020
Table Global Erectile Dysfunction (ED) Drugs Sales by Types (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Sales Share by Types (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Revenue ($) by Types (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Revenue Share by Types (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Price ($) by Types (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Sales by Types (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Sildenafil Citrate (Viagra) Sales and Growth Rate (2015-2020)
Figure Global Sildenafil Citrate (Viagra) Price (2015-2020)
Figure Global Vardenafil (Levitra/ Staxyn) Sales and Growth Rate (2015-2020)
Figure Global Vardenafil (Levitra/ Staxyn) Price (2015-2020)
Figure Global Tadalafil (Cialis) Sales and Growth Rate (2015-2020)
Figure Global Tadalafil (Cialis) Price (2015-2020)
Figure Global Udenafil (Zydena) Sales and Growth Rate (2015-2020)
Figure Global Udenafil (Zydena) Price (2015-2020)
Figure Global Lodenafil Carbonate (Helleva) Sales and Growth Rate (2015-2020)
Figure Global Lodenafil Carbonate (Helleva) Price (2015-2020)
Figure Global Stendra/ Spedra (Avanafil) Sales and Growth Rate (2015-2020)
Figure Global Stendra/ Spedra (Avanafil) Price (2015-2020)
Figure Global Mirodenafil (Mvix) Sales and Growth Rate (2015-2020)
Figure Global Mirodenafil (Mvix) Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Sildenafil Citrate (Viagra) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Sildenafil Citrate (Viagra) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Vardenafil (Levitra/ Staxyn) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Vardenafil (Levitra/ Staxyn) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Tadalafil (Cialis) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Tadalafil (Cialis) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Udenafil (Zydena) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Udenafil (Zydena) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Lodenafil Carbonate (Helleva) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Lodenafil Carbonate (Helleva) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Stendra/ Spedra (Avanafil) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Stendra/ Spedra (Avanafil) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Mirodenafil (Mvix) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Mirodenafil (Mvix) (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Others (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Sales by Applications (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Sales Share by Applications (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Revenue ($) by Applications (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Revenue Share by Applications (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Hospital Pharmacies Sales and Growth Rate (2015-2020)
Figure Global Hospital Pharmacies Price (2015-2020)
Figure Global Retail Pharmacies Sales and Growth Rate (2015-2020)
Figure Global Retail Pharmacies Price (2015-2020)
Figure Global Online Sales Sales and Growth Rate (2015-2020)
Figure Global Online Sales Price (2015-2020)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Hospital Pharmacies (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Hospital Pharmacies (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Retail Pharmacies (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Retail Pharmacies (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Market Revenue ($) and Growth Rate Forecast of Online Sales (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate Forecast of Online Sales (2020-2025)
Figure Global Erectile Dysfunction (ED) Drugs Sales and Growth Rate (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Sales by Regions (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Sales Market Share by Regions (2015-2020)
Figure Global Erectile Dysfunction (ED) Drugs Sales Market Share by Regions in 2019
Figure Global Erectile Dysfunction (ED) Drugs Revenue and Growth Rate (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Revenue by Regions (2015-2020)
Table Global Erectile Dysfunction (ED) Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Erectile Dysfunction (ED) Drugs Revenue Market Share by Regions in 2019
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Erectile Dysfunction (ED) Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Erectile Dysfunction (ED) Drugs Market Forecast Sales (2020-2025)
Figure North America Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Erectile Dysfunction (ED) Drugs Market Forecast Sales (2020-2025)
Figure Europe Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure France Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Erectile Dysfunction (ED) Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure India Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Erectile Dysfunction (ED) Drugs Market Forecast Sales (2020-2025)
Figure South America Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Erectile Dysfunction (ED) Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Erectile Dysfunction (ED) Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Erectile Dysfunction (ED) Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Erectile Dysfunction (ED) Drugs Market Sales and Growth Rate (2015-2020)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|